Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial

PURPOSE: Proton therapy (PT) for partial breast irradiation (PBI) in early-stage breast cancer can decrease morbidity versus photon PBI with superior organs-at-risk sparing. We report 3-year outcomes of the first prospective, multicenter, phase II trial of proton PBI. METHODS AND MATERIALS: This Pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, J. Isabelle, Prabhu, Kiran, Hartsell, William F., DeWees, Todd, Sinesi, Christopher, Vargas, Carlos, Benda, Rashmi K., Cahlon, Oren, Chang, Andrew L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450061/
https://www.ncbi.nlm.nih.gov/pubmed/36093343
http://dx.doi.org/10.1016/j.ctro.2022.08.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450061/
https://www.ncbi.nlm.nih.gov/pubmed/36093343
http://dx.doi.org/10.1016/j.ctro.2022.08.013

Ejemplares similares